注册以创建品种、
财经事件和所关注作者内容的提醒
免费注册 已有账户? 登录
代码 | 交易平台 | 货币 | ||
---|---|---|---|---|
MRNA | 纳斯达克 | USD | 实时 | |
MRNA | 墨西哥 | MXN | 延迟 | |
MRNA | 米兰 | EUR | 实时 | |
0QF | 德国法兰克福 | EUR | 延迟 | |
0QF | TradeGate | EUR | 延迟 | |
0QF | 法兰克福 | EUR | 延迟 | |
MRNAm | 阿根廷 | ARS | 延迟 | |
M1RN34 | B3 | BRL | 延迟 | |
MRNA | 奥地利维也纳 | EUR | 实时 | |
MRNA_KZ | 卡萨克斯坦 | USD | 延迟 | |
MRNA | 秘鲁利马 | USD | 延迟 |
Moderna Inc是一家生物技术公司。该公司专注于开发信使核糖核酸(mRNA)疗法和疫苗。该公司独立并与其战略合作伙伴一起开发传染病、免疫肿瘤学、罕见病、自身免疫和心血管疾病的治疗药物和疫苗。mRNA药物旨在引导人体细胞产生细胞内、膜或分泌蛋白,这些蛋白具有治疗或预防作用,有可能解决一系列疾病。该公司的产品包括Spikevax、Moderna COVID-19疫苗(mRNA-1273)、一种针对BA.1 Omicron变体的二价疫苗,结合Spikevax(mRNA-1273.214),以及针对BA.4/BA.5的二价疫苗Omicron变体结合Spikevax (mRNA-1273.222)。该公司在其48个开发项目中拥有45个开发候选人的开发管道,其中38个正在进行临床研究。
名称 | 年龄 | 任期 | 标题 |
---|---|---|---|
Noubar B. Afeyan | 60 | 2010 | Co-Founder, Independent Non Executive Chairman & Member of Technology Advisory Board |
Stephane Bancel | 50 | 2011 | CEO & Director |
Melissa J. Moore | - | 2016 | Member of Scientific Advisory Board |
Jack W. Szostak | - | 2014 | Chairman of Scientific Advisory Board |
Richard C. Willson | - | 2014 | Member of Technology Advisory Board |
Fred E. Regnier | - | 2014 | Member of Technology Advisory Board |
John G. Aunins | 63 | 2014 | Member of Technology Advisory Board |
James R. Swartz | - | 2014 | Member of Technology Advisory Board |
Elizabeth G. Nabel | 72 | 2021 | Independent Director |
Elizabeth Edith Tallett | 74 | 2020 | Independent Director |
Ulrich H. von Andrian-Werburg | - | - | Member of Scientific Advisory Board |
Francois Nader | 67 | 2019 | Independent Non Executive Director |
Robert S. Langer | 75 | 2010 | Member of Scientific Advisory Board |
Paula T. Hammond | 60 | - | Member of Scientific Advisory Board |
Ron Eydelloth | - | - | Member of Scientific Advisory Board |
Paul L. Sagan | 65 | 2018 | Independent Non Executive Director |
Ralph Weissleder | - | - | Member of Scientific Advisory Board |
Sandra J. Horning | 75 | 2020 | Independent Director |
Rachel Green | - | - | Member of Scientific Advisory Board |
Michael Diamond | - | - | Member of Scientific Advisory Board |
David Mark Rubenstein | 75 | 2024 | Director |
Shah Abbas Hussain | 59 | 2024 | Director |
确定屏蔽%USER_NAME%?
如果屏蔽,您和%USER_NAME%都无法看到相互在Investing.com上发布的信息。
%USER_NAME%已成功添加至屏蔽列表
由于您刚刚取消屏蔽此人,因此必须等待48小时才能重新屏蔽。
您举报该评论的原因为:
谢谢您!
您的举报将会被发送到管理员进行审核